Give your voice to help COVID-19 research
15 December 2020
Luxembourg Institute of Science and Technology (LIST) is currently conducting a research project on the detection of COVID-19 via cough and voice analysis.
Luxembourg Institute of Science and Technology (LIST) currently has many areas of research regarding the COVID-19 pandemic.One intriguing direction of research is the detection of COVID-19 via cough and voice analysis to help emergency services identify critical cases needing rapid intervention.This is done with the use of artificial intelligence to detect a COVID-19 signature that can be present in voice and in coughs.
The research project currently being carried out at LIST is called CDCVA or COVID-19 Detection by Cough and Voice Analysis. While most Coronavirus diagnoses require a physical consultations, which increases the risk of infection for staff and patients, and consume significant amounts of health system resources, the CDCVA system can be done remotely.
This exciting research could eventually lead to rapid detection of COVID-19 just through a simple telephone call.
“Respiratory conditions, such as dry cough, sore throat, excessively breathy voice and dyspnoea, caused by Covid-19, can make patients’ voices distinctive, creating identifiable voice signatures, that may be discovered using our system”, explained the project leader Muhannad Ismael.
However, the project is still in the early testing phase and LIST recently launched an appeal to the public to take a five-minute survey that includes taking vocal samples via computer or smartphone microphone.
Reaching Luxembourg and beyond
Since then over 400 samples have been taken via the online survey, but more data and completed surveys the system receives, the more it can learn and improve in the battle against COVID-19.
Therefore, the move now is to not only appeal for more vocal samples in Luxembourg, but beyond the borders too, and with that in mind three more languages; Arabic Serbian and Portuguese, have been added to the list of languages the survey can be carried out in.
“We decided to add them to reach more people from around the world. The platform is now available in eight languages and we are open to adding more soon!” said Muhannad, before adding “now, our plan is to reach out the media outside Luxembourg. At the same time, we are looking at working with the health ministry to help us by informing COVID-19 patients of the survey.”
CDCVA is also supported by the Luxembourg Institute of Health and the University of Luxembourg.
Take the survey !
Would you like to take part? It’s easy and takes about five minutes to do. The survey asks you for some general information, before asking you to record saying “aaaahhh”, cough, and read a short text. Of course everything is totally anonymous. Full details are explained on the CDCVA website.
Choose link in your language
A pioneering study using vocal biomarkers to monitor COVID-19The Predi-COVID Cohort study, a project led by Dr Guy Fagherazzi of the Luxembourg Institute of Health (LIH), showed for…
OECD Report – Evaluation of Luxembourg’s response to the COVID-19 pandemicIn a report presented on the 5th of October 2022, the OECD analyses Luxembourg’s response to the COVID-19 pandemic. The…
Multiple Types of Long COVID Identified for the First TimeA consortium of Luxembourgish research institutions studying the national population have been looking to identify factors that may contribute to…
Physical activity to reduce the severity of COVID-19A consortium of Luxembourgish research institutions studying the national population have been looking to identify factors that may contribute to…
Superimmunity: A defence mechanism against COVID-19?Two years after the pandemic outbreak, researchers and scientists continue to look at the immune system’s defence mechanisms against the…
The why behind mild COVID-19From the start of the COVID-19 pandemic, the majority of published studies have focused on severe COVID-19 patients in order…
In conversation with our young researchers: Abir ElbéjiHow to better follow COVID-19-related symptoms thanks to new digital biomarkers and tools and how to improve Long Covid patients’…
Shedding light on COVID-19 – Presentation of CoVaLuxDespite the worldwide COVID-19 pandemic entering its third year, open questions pertaining to the occurrence of new variants, ensuing new…